{"id":6397,"date":"2024-02-19T18:25:01","date_gmt":"2024-02-19T18:25:01","guid":{"rendered":"https:\/\/els-solutions.com\/cms\/dev\/?p=6397"},"modified":"2024-06-03T11:39:57","modified_gmt":"2024-06-03T10:39:57","slug":"anvisa-publishes-ggmed-management-report","status":"publish","type":"post","link":"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/","title":{"rendered":"Anvisa publishes GGMED Management Report"},"content":{"rendered":"<\/p>\n

Anvisa publishes GGMED Management Report<\/strong><\/p>\n

Anvisa has published the GGMED Management Report<\/strong>, highlighting advances in drug regulation in Brazil, emphasizing the importance of human capital and strategies to improve processes.<\/p>\n

The document shows record drug registrations, reflecting efficiency and commitment to innovation policies. It also discusses the expansion of regulatory collaboration, the challenges of speeding up analyses and technological modernization, pointing to future strategies for tackling regulatory challenges. Read more here<\/span><\/a><\/p>\n

If you need more regulatory information for your sunscreens, ELS can help you with our wide range of services for your products.<\/p>\n

Please do not hesitate to c<\/span>ontact your local ELS consultant<\/a>\u00a0or via email info@elssolutions.pt<\/p>\n

\n","protected":false},"excerpt":{"rendered":"

The record number of approvals shows the Agency’s progress in terms of efficiency and commitment to generics and innovation policies.<\/p>\n","protected":false},"author":9,"featured_media":6394,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_joinchat":[],"footnotes":""},"categories":[54,61],"tags":[62],"class_list":["post-6397","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","category-news","tag-news"],"yoast_head":"\nANVISA - GGMED Management Report<\/title>\n<meta name=\"description\" content=\"The record number of approvals shows the Agency's progress in terms of efficiency and commitment to generics and innovation policies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa publishes GGMED Management Report\" \/>\n<meta property=\"og:description\" content=\"The record number of approvals shows the Agency's progress in terms of efficiency and commitment to generics and innovation policies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/\" \/>\n<meta property=\"og:site_name\" content=\"ELS Group - Accelerating Innovation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/els.solutions\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-19T18:25:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-03T10:39:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/02\/ELS-Solutions-Anvisa-publishes-GGMED-Management-Report-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marketing ELS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing ELS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/\"},\"author\":{\"name\":\"Marketing ELS\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\"},\"headline\":\"Anvisa publishes GGMED Management Report\",\"datePublished\":\"2024-02-19T18:25:01+00:00\",\"dateModified\":\"2024-06-03T10:39:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/\"},\"wordCount\":837,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/02\/ELS-Solutions-Anvisa-publishes-GGMED-Management-Report-1.jpg\",\"keywords\":[\"News\"],\"articleSection\":[\"General\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/\",\"url\":\"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/\",\"name\":\"ANVISA - GGMED Management Report\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/02\/ELS-Solutions-Anvisa-publishes-GGMED-Management-Report-1.jpg\",\"datePublished\":\"2024-02-19T18:25:01+00:00\",\"dateModified\":\"2024-06-03T10:39:57+00:00\",\"description\":\"The record number of approvals shows the Agency's progress in terms of efficiency and commitment to generics and innovation policies.\",\"breadcrumb\":{\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#primaryimage\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/02\/ELS-Solutions-Anvisa-publishes-GGMED-Management-Report-1.jpg\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/02\/ELS-Solutions-Anvisa-publishes-GGMED-Management-Report-1.jpg\",\"width\":1200,\"height\":600,\"caption\":\"Anvisa GGMED Management Report\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/els-solutions.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa publishes GGMED Management Report\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/els-solutions.com\/en\/#website\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"name\":\"ELS Group - Accelerating Innovation\",\"description\":\"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica\",\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/els-solutions.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\",\"name\":\"ELS Group - Accelerating Innovation\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"width\":2226,\"height\":1080,\"caption\":\"ELS Group - Accelerating Innovation\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/els.solutions\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\",\"name\":\"Marketing ELS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"caption\":\"Marketing ELS\"},\"sameAs\":[\"https:\/\/els-solutions.com\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANVISA - GGMED Management Report","description":"The record number of approvals shows the Agency's progress in terms of efficiency and commitment to generics and innovation policies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/","og_locale":"en_US","og_type":"article","og_title":"Anvisa publishes GGMED Management Report","og_description":"The record number of approvals shows the Agency's progress in terms of efficiency and commitment to generics and innovation policies.","og_url":"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/","og_site_name":"ELS Group - Accelerating Innovation","article_publisher":"https:\/\/www.facebook.com\/els.solutions\/","article_published_time":"2024-02-19T18:25:01+00:00","article_modified_time":"2024-06-03T10:39:57+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/02\/ELS-Solutions-Anvisa-publishes-GGMED-Management-Report-1.jpg","type":"image\/jpeg"}],"author":"Marketing ELS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marketing ELS","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#article","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/"},"author":{"name":"Marketing ELS","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3"},"headline":"Anvisa publishes GGMED Management Report","datePublished":"2024-02-19T18:25:01+00:00","dateModified":"2024-06-03T10:39:57+00:00","mainEntityOfPage":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/"},"wordCount":837,"commentCount":0,"publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"image":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/02\/ELS-Solutions-Anvisa-publishes-GGMED-Management-Report-1.jpg","keywords":["News"],"articleSection":["General","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/","url":"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/","name":"ANVISA - GGMED Management Report","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#primaryimage"},"image":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/02\/ELS-Solutions-Anvisa-publishes-GGMED-Management-Report-1.jpg","datePublished":"2024-02-19T18:25:01+00:00","dateModified":"2024-06-03T10:39:57+00:00","description":"The record number of approvals shows the Agency's progress in terms of efficiency and commitment to generics and innovation policies.","breadcrumb":{"@id":"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#primaryimage","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/02\/ELS-Solutions-Anvisa-publishes-GGMED-Management-Report-1.jpg","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2024\/02\/ELS-Solutions-Anvisa-publishes-GGMED-Management-Report-1.jpg","width":1200,"height":600,"caption":"Anvisa GGMED Management Report"},{"@type":"BreadcrumbList","@id":"https:\/\/els-solutions.com\/en\/anvisa-publishes-ggmed-management-report\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/els-solutions.com\/en\/"},{"@type":"ListItem","position":2,"name":"Anvisa publishes GGMED Management Report"}]},{"@type":"WebSite","@id":"https:\/\/els-solutions.com\/en\/#website","url":"https:\/\/els-solutions.com\/en\/","name":"ELS Group - Accelerating Innovation","description":"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/els-solutions.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/els-solutions.com\/en\/#organization","name":"ELS Group - Accelerating Innovation","url":"https:\/\/els-solutions.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","width":2226,"height":1080,"caption":"ELS Group - Accelerating Innovation"},"image":{"@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/els.solutions\/"]},{"@type":"Person","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3","name":"Marketing ELS","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","caption":"Marketing ELS"},"sameAs":["https:\/\/els-solutions.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/6397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/comments?post=6397"}],"version-history":[{"count":2,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/6397\/revisions"}],"predecessor-version":[{"id":6409,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/6397\/revisions\/6409"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media\/6394"}],"wp:attachment":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media?parent=6397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/categories?post=6397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/tags?post=6397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}